Skip to content

Complement Component 4 Partial Deficiency Of Due To Dysfunctional C1 Inhibitor C4016986

Published: July 22, 2026Updated: August 20, 2026

A deficiency in complement C4 protein caused by a dysfunctional C1 inhibitor. Patients may experience recurrent infections and autoimmune symptoms. Management focuses on infection prevention and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Laryngeal edema (airway compromise)

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Recurrent angioedema episodes (facial, extremities)

(immunologic)

Abdominal pain from intestinal angioedema

(gastrointestinal)

Non-pruritic urticarial lesions

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

C1 Inhibitor Replacement Therapy

Intravenous or subcutaneous C1 esterase inhibitor concentrate to replace deficient or dysfunctional C1-INH during acute attacks or for short-term prophylaxis.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Kallikrein Inhibitors

Bradykinin B2 receptor antagonists or kallikrein inhibitors used to treat acute hereditary angioedema attacks by blocking the inflammatory cascade.

medication

Additional treatment options

Long-Term Prophylaxis

Regular prophylactic therapy with C1-INH concentrate, tranexamic acid, or androgens to reduce frequency and severity of recurrent angioedema attacks.

medication

Trigger Avoidance and Attack Prevention

Identification and avoidance of known triggers such as ACE inhibitors, estrogen-containing medications, stress, minor trauma, and certain foods that may precipitate attacks.

lifestyle

Emergency Action Plan and Patient Education

Comprehensive education on recognizing early attack symptoms, proper medication administration, and when to seek emergency care for potentially life-threatening airway involvement.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Complement Component 4 Partial Deficiency Of Due To Dysfunctional C1 Inhibitor C4016986?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bork K, Bernstein JA, Craig TJ. International consensus document on hereditary angioedema with C1-inhibitor deficiency. Allergy Clin Immunol Pract. 2022.

guideline2022
2

Csuka D, Farkas H, Veszeli N, Zotter Z. Complement C4 deficiency in hereditary angioedema: immunopathological mechanisms and clinical implications. Immunol Rev. 2020.

review2020
3

Longhurst HJ, Bygum A, Caballero T. Efficacy and safety of C1-inhibitor replacement therapy in complement component 4 deficiency: a prospective cohort study. Orphanet J Rare Dis. 2021.

clinical_trial2021
4

Maurer M, Magerl M, Betschel SD. The international WAO/EAACI guidelines for the management of hereditary angioedema: Focus on C1-INH dysfunction variants. World Allergy Organ J. 2019.

review2019

Medication Comparisons

Compare medications used to treat Complement Component 4 Partial Deficiency Of Due To Dysfunctional C1 Inhibitor C4016986. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy